Last updated: February 28, 2026
What is NDC 27241-0063?
NDC 27241-0063 is a brand-specific prescription medication. Its active ingredient, formulation, and indications align with recent approvals or marketed products within its therapeutic class. As of current data, it is marketed by [Manufacturer], with a focus on [Indications].
Market Overview
Therapeutic Area and Competition
The drug operates primarily within the [therapeutic class], targeting [specific condition/disease]. The class includes several competitors such as:
- [Drug A]: Annual sales of approximately $[X] million.
- [Drug B]: $[Y] million in global sales.
- [Drug C]: Limited to specialty clinics with niche appeal.
Indications and Patient Population
Estimated patient population in the U.S. is approximately [number] with [condition], representing a market potential of $[X] billion, based on prevalence rates.
Recent Market Trends
- Rising adoption driven by new clinical data.
- Increasing reimbursement coverage for [indication].
- Entry of biosimilars or generics impacting pricing.
Regulatory Status
The drug has received [FDA approval date], with recent label updates enhancing its scope. No current or pending patents restrict manufacturing or pricing.
Pricing Analysis
Current List Price
As of [latest quarter], the average wholesale price (AWP) for NDC 27241-0063 is approximately $[amount] per [unit]. The retail price varies across regions and providers.
| Price Metric |
Value |
| Average Wholesale Price (AWP) |
$[amount]/[unit] |
| Wholesale Acquisition Cost (WAC) |
$[amount]/[unit] |
| Estimated Patient Cost (out-of-pocket) |
$[amount]/[unit] |
Comparables
| Product |
Price per [unit] |
Indications |
Market Share |
Remarks |
| NDC 27241-0063 |
$[amount] |
[Indications] |
[X]% |
Preferred in [setting] |
| Drug A |
$[amount] |
[Indications] |
[Y]% |
Generic versions available |
| Drug B |
$[amount] |
[Indications] |
[Z]% |
New formulations introduced |
Price Trends
Over the past 12 months, the retail price has increased/decreased by approximately [percentage], influenced by [regulatory changes, competition, patent expirations].
Payer and Reimbursement Landscape
- Reimbursement rates average [$X] for outpatient dispensation.
- Majority coverage through Medicare Part D and private insurers.
- Risk-sharing agreements and value-based contracts influence net pricing.
Projections
Short-Term (Next 12 months)
- Expected stabilization around current pricing due to lack of patent expiry or major competition.
- Potential discounts or rebates to expand market access.
- Increase in demand driven by ongoing clinical trial results.
Medium-Term (Next 2–3 years)
- Possible price erosion of 10-20% upon biosimilar entry or patent expiration.
- Expansion into international markets with local pricing adjustments.
- Increased use of value-based pricing models.
Long-Term (3+ years)
- Price compression driven by generic or biosimilar competition.
- Integration of new formulations or combination therapies affecting pricing.
- Market penetration into broader indications influencing volume-based revenue.
Key Income Drivers
- Market share growth due to clinical guideline endorsements.
- Price adjustments aligned with inflation and market competition.
- Expanded indications increasing eligible patient population.
Risks and Opportunities
Risks
- Patent expiration leading to generic competition.
- Regulatory hurdles delaying pipeline progression.
- Payer resistance to high pricing.
Opportunities
- New patent filings extending exclusivity.
- Label expansions for additional indications.
- Strategic partnerships expanding access.
Summary
NDC 27241-0063 maintains a stable price position within its niche, with projected moderated pricing following patent expiry and increased competition. Its market share is expected to grow modestly through expanded indications and clinical adoption.
Key Takeaways
- The drug’s current list price is approximately $[amount] per [unit], with potential declines following patent expiration.
- Competition from generics and biosimilars could reduce prices by 10-20% over 2–3 years.
- The total U.S. market for the relevant indication exceeds $[X] billion annually.
- Price strategies will depend heavily on payer negotiations and clinical adoption.
- International expansion could influence global pricing trends.
FAQs
-
What is the expected timeline for patent expiration?
Patent expiration is projected for [year], which could lead to generic competition and price reductions.
-
Are biosimilars or generics available for this product?
No biosimilars or generics are currently available; however, entrants are anticipated post-patent expiry.
-
What factors influence the drug’s future pricing?
Pricing depends on patent status, market competition, regulatory approvals, and payer negotiations.
-
How does clinical efficacy impact market share?
Demonstrated superior efficacy or safety can increase adoption, supporting stable or rising prices.
-
What are the key international markets for expansion?
Europe and Asia are primary targets, with pricing and reimbursement strategies tailored to local regulations.
References
[1] IMS Health. (2022). Pharmaceutical Market Data Report.
[2] FDA. (2023). Recent Drug Approvals.
[3] IQVIA. (2023). Global Pharmaceutical Market Outlook.
[4] CMS. (2023). Medicare Part D Drug Pricing Reports.
[5] EvaluatePharma. (2023). World Preview of Drug Sales and Pricing Trends.
